Financial Management Professionals, Inc. Fate Therapeutics Inc Transaction History

Financial Management Professionals, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2019 Oct 11, 2019	SELL	$15.47 - $22.5 $15,470 - $22,500	-1,000 Closed	0 $0
Q2 2019 Jul 29, 2019	BUY	$15.61 - $20.44 $15,610 - $20,440	1,000 New	1,000 $20,000

175

115M

53.7K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $260M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Financial Management Professionals, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Management Professionals, Inc. with notifications on news.